SU458966A3 - The method of producing tablets - Google Patents

The method of producing tablets

Info

Publication number
SU458966A3
SU458966A3 SU1247008A SU1247008A SU458966A3 SU 458966 A3 SU458966 A3 SU 458966A3 SU 1247008 A SU1247008 A SU 1247008A SU 1247008 A SU1247008 A SU 1247008A SU 458966 A3 SU458966 A3 SU 458966A3
Authority
SU
USSR - Soviet Union
Prior art keywords
core
producing tablets
tablets
pressure
ascorbic acid
Prior art date
Application number
SU1247008A
Other languages
Russian (ru)
Inventor
Раймонд Делаби Пьер-Андрэ
Original Assignee
Ле Лаборатуар Досс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Досс filed Critical Ле Лаборатуар Досс
Application granted granted Critical
Publication of SU458966A3 publication Critical patent/SU458966A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
    • C04B41/45—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements
    • C04B41/50—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials
    • C04B41/5025—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials with ceramic materials
    • C04B41/5042—Zirconium oxides or zirconates; Hafnium oxides or hafnates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ceramic Engineering (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Structural Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ ТАБЛЕТОК(54) METHOD FOR GETTING TABLETS

Изобретение относитс  к фармацевтической промышлеииости.This invention relates to the pharmaceutical industry.

Известен способ получени  таблеток путем прессовани   дра с веществом, замедл ющим растворимость оболочки.A known method of producing tablets by pressing a core with a substance that slows the solubility of the shell.

Целью изобретени   вл етс  улучшение распадаемости таблеток.The aim of the invention is to improve the disintegration of tablets.

Дл  этого  дро прессуют под давлением 225-600 кг/см, первый слой - под давлением 450-750 кг/см2, а второй -900-1200 кг/см. For this, the cores are pressed under a pressure of 225-600 kg / cm, the first layer - under a pressure of 450-750 kg / cm2, and the second one –900-1200 kg / cm.

Ядро таблетки окружено одной или несколькими оболочками. В одну или в несколько из них ввод т ингредиенты-замедлители, измен ющие количество, в котором они присутствуют , и/или его природу таким образом, чтобы двум соседним элементам соответствовали различные длительности расслоени . В.качестве ингредиентов-замедлителей могут быть использованы гуммилак, стеаринова  кислота и ее соли и эфиры, например стеарат .магни , белый воск, растительные воска, такие как воск Карноба, полиалкиленгликоли, полиэтиленгликоль 4000, диоктилсульфосукцинат натри , ацетофталат целлюлозы, в некоторых случа х вместе с фталевым эфиром, таким как этиловый или бутиловый эфир фталевой кислоты .The core of the tablet is surrounded by one or more shells. In one or more of them, inhibitor ingredients are introduced, varying the amount in which they are present and / or its nature in such a way that the different elements of stratification correspond to the two adjacent elements. C. Gummilac, stearic acid and its salts and esters can be used as moderating ingredients, e.g. magnesium stearate, white wax, vegetable waxes such as Carnoba wax, polyalkylene glycols, polyethylene glycol 4000, dioctyl sodium sulfosuccinate, cellulose acetal phthalate, in some cases together with phthalate ester, such as phthalic acid ethyl or butyl ester.

Каждый элемент таблетки, который должен отслоитс  с малой скоростью, может содержать один или несколько ингредиентов-замедлителеи и одно или несколько активных начал. Аскорбиновую кислоту гранулируют с лаковой камедью (3 вес. %) в спиртовом растворе при перемешивании. Оставшийс  раствор используют дл  гранулировани  остальных компонентов . Два гранул та высушивают на воздухе , а затем смешивают и таблетируют  дро весом 0,110 т под давлением 7 т/см.Each element of the tablet, which should exfoliate at low speed, may contain one or more inhibiting ingredients and one or more active principles. Ascorbic acid is granulated with lacquer gum (3 wt.%) In an alcohol solution with stirring. The remaining solution is used to granulate the remaining components. The two granules are air dried, and then a core weighing 0.110 tons is mixed and tableted under a pressure of 7 tons / cm.

Компоненты первого сло  предварительно обрабатывают и смешивают таким же образом , как и компоненты  дра, но количество лаковой камеди, примен емой дл  гранулировани  аскорбиновой кислоты, составл ет 0,15 вес.%. Смесь нанос т на  дро п таблетируют на нем первый слой весом 0,120 г под давлением 5 т/см. Пример 1. Состав  дра, т:The components of the first layer are pretreated and mixed in the same manner as the core components, but the amount of lacquer gum used for granulating ascorbic acid is 0.15% by weight. The mixture is applied to the core and the first layer weighing 0.120 g is pressed on it under a pressure of 5 tons / cm. Example 1. The composition of the core, t:

Хлоргидрат папаверина 0,034 Этоксазорутин0,025Papaverine hydrochloride 0.034 Ethoxazorutine 0.025

Аскорбинова  кислота0,025Ascorbic Acid

Лакова  камедьLakova gum

(в 95%-ном спирте)0,015(in 95% alcohol) 0.015

Стеарат магни 0,010Magnesium stearate 0,010

Тальк0,001Talc0.001

Первый слой, т:The first layer, t:

Хлоргидрат папаверина0,033Papaverine hydrochloride0,033

Этоксазорутин0,025Ethoxazorutin0.025

Аскорбинова  кислота0,025Ascorbic Acid

SU1247008A 1967-06-15 1968-06-14 The method of producing tablets SU458966A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR110534A FR1545612A (en) 1967-06-15 1967-06-15 Tablet manufacturing process

Publications (1)

Publication Number Publication Date
SU458966A3 true SU458966A3 (en) 1975-01-30

Family

ID=8633106

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1247008A SU458966A3 (en) 1967-06-15 1968-06-14 The method of producing tablets

Country Status (10)

Country Link
BE (1) BE716530A (en)
DE (1) DE1767765A1 (en)
ES (1) ES355054A1 (en)
FR (1) FR1545612A (en)
GB (1) GB1233055A (en)
IL (1) IL30165A (en)
IT (1) IT954035B (en)
LU (1) LU56264A1 (en)
NL (1) NL151902B (en)
SU (1) SU458966A3 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
RU2531553C2 (en) * 1994-07-08 2014-10-20 Астразенека Аб Tabletted multiunit dosage form, method for preparing it, pack and method for inhibiting gastric acid secretion and/or treating gastrointestinal inflammatory diseases
RU2538511C2 (en) * 1994-07-08 2015-01-10 Астра Актиеболаг Tabletted multiunit dosage, method of its obtaining and method for inhibiting gastric acid secretion or treating gastrointestinal diseases in mammals and humans

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
SE418247B (en) * 1975-11-17 1981-05-18 Haessle Ab SET TO MAKE BODIES WITH REGULATED RELEASE OF AN ACTIVE COMPONENT
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
DK62184D0 (en) * 1984-02-10 1984-02-10 Benzon As Alfred DIFFUSION COATED POLYDEPOT PREPARATION
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2531553C2 (en) * 1994-07-08 2014-10-20 Астразенека Аб Tabletted multiunit dosage form, method for preparing it, pack and method for inhibiting gastric acid secretion and/or treating gastrointestinal inflammatory diseases
RU2538511C2 (en) * 1994-07-08 2015-01-10 Астра Актиеболаг Tabletted multiunit dosage, method of its obtaining and method for inhibiting gastric acid secretion or treating gastrointestinal diseases in mammals and humans
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US8383579B2 (en) 2004-11-19 2013-02-26 GlaxoSmithKline, LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies

Also Published As

Publication number Publication date
ES355054A1 (en) 1969-11-16
BE716530A (en) 1968-11-04
DE1767765A1 (en) 1972-03-30
LU56264A1 (en) 1968-09-23
NL151902B (en) 1977-01-17
IL30165A0 (en) 1968-08-22
FR1545612A (en) 1968-11-15
IL30165A (en) 1973-04-30
IT954035B (en) 1973-08-30
NL6808312A (en) 1968-12-16
GB1233055A (en) 1971-05-26

Similar Documents

Publication Publication Date Title
SU458966A3 (en) The method of producing tablets
KR840005661A (en) Process for preparing a persistent matrix tablet composition
GB1235787A (en) Sustained release pharmaceutical tablets
KR840006437A (en) Method of Preparation of Formulation for Oral Antibiotic Administration
ES264040A1 (en) Pharmaceutical formulations and their manufacture
GB1272640A (en) Delayed or sustained release medicament dosages and a process for their manufacture
GB1002211A (en) Method of preparing sustained release pharmaceutical tablets
IL34148A0 (en) Esters of amino methyl-4-hydroxybenzyl alcohols,process for their preparation and compositions containing them
US3136695A (en) Anhydrous thixotropic gel sustained release therapeutic compositions and method of preparation
GB1513166A (en) Method of making granules
US2980589A (en) Process for producing anhydrous granulation of a medicinally active waterlabile powder
ES8205353A1 (en) Sustained release tablets
US3493659A (en) Compositions and process for the production thereof
IL35564A0 (en) Esters of substituted anthranilic acid,their preparation and pharmaceutical compositions containing them
ES441204A1 (en) Pharmaceutical composition
ES388917A1 (en) Procedure for the production of solid microgranulate, spherical, free-fluency. (Machine-translation by Google Translate, not legally binding)
GB1238811A (en)
ES397668A1 (en) Interesterification of glycerides in the presence of an aliphatic ketone
JPS51122383A (en) Semiconductor memory
JPS51123531A (en) Diode memory
ES419603A1 (en) Pharmaceutical preparations containing pyrazolones
ES372290A1 (en) The supplying of water to an animal
ES347878A2 (en) Procedure for the preparation of surgical compositions. (Machine-translation by Google Translate, not legally binding)
ES381545A1 (en) Procedure for the obtaining of thermoplastic molding compounds. (Machine-translation by Google Translate, not legally binding)
ES361494A1 (en) Procedure for the preparation of medicines with prolonged release of active substance. (Machine-translation by Google Translate, not legally binding)